5 simple steps to OA joint pain relief
How to use Voltaren® Gel
Rubbing in Voltaren Gel 4 times a day may turn the treatment of persistent OA joint pain into a positive habit that provides prescription OA joint pain relief. Follow these 5 simple steps to achieve maximum results and lessen your OA joint pain:

Please see the Voltaren Gel medication guide included with your prescription for full application instructions.
Work with your doctor to find your Voltaren Gel Pack number
It’s important to know how much Voltaren Gel you need to relieve your OA joint pain. The amount will vary depending on what part or parts of the body are affected. Consistently applying
Voltaren Gel 4 times a day as directed provides optimal OA joint pain relief.

Remember
- OA joint pain is a persistent condition that may require effective relief
- To get the full benefit of Voltaren Gel, be sure to use it
as prescribed - Massage Voltaren Gel directly into painful joints 4 times a day, using your 3 Pack or 5 Pack per joint, every month as directed
For U.S. Only
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Important Safety Information
*Voltaren® Gel is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. Voltaren Gel has not been evaluated for use on the spine, hip, or shoulder.
Cardiovascular Risk
- Nonsteroidal anti-inflammatory drugs (NSAIDs) may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk [see Warnings and Precautions].
- Voltaren Gel is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery [see Contraindications].
Gastrointestinal Risk
- NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events [see Warnings and Precautions].
The most common adverse reactions reported in Voltaren Gel clinical trials were application site reactions in 7% of treated patients. With all NSAIDs there may be an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.
The use of Voltaren Gel is contraindicated in patients with a known hypersensitivity to diclofenac.
Voltaren Gel should not be administered in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.
Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. Similarly, combined use of Voltaren Gel with other topical products, such as sunscreens and cosmetics, on the same skin area has not been tested and should be avoided because of the potential to alter local tolerability and absorption.
There is a potential for elevation in liver function tests during treatment with diclofenac containing products.
Safety and effectiveness in pediatric patients have not been established.
Please see full Prescribing Information for Warnings and Contraindications.



